Clinical decision‐making during 5 years of antipsychotic treatment

Diagnostic and Statistical Manual of Mental Disorders

2022 • 16,313 citations

A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity

1983 • 993 citations

Metacognition amidst narratives of self and illness in schizophrenia: associations with neurocognition, symptoms, insight and quality of life

2005 • 500 citations

Shared decision making in psychiatry

2003 • 278 citations

Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change

2003 • 147 citations

Compliance in Schizophrenia: Psychopathology, Side Effects, and Patients’ Attitudes Toward the Illness and Medication

2004 • 128 citations

Subjective well‐being under neuroleptic treatment and its relevance for compliance

2005 • 106 citations

Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia: Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat)

2001 • 101 citations

Needs of people with severe mental illness

2006 • 100 citations

Dose requirement and prolactin elevation of antipsychotics in male and female patients with schizophrenia or related psychoses

2001 • 93 citations

Sex differences in clinical response to olanzapine compared with haloperidol

2002 • 84 citations

Variations in Use of Second-Generation Antipsychotic Medication by Race Among Adult Psychiatric Patients

2004 • 67 citations

The Swedish version of the Positive and Negative Syndrome Scale (PANSS) for schizophrenia

1992 • 64 citations

Medical Decision Making in Antipsychotic Drug Choice for Schizophrenia

2004 • 59 citations

The European Schizophrenia Outpatient Health Outcomes Study: baseline findings across country and treatment

2003 • 57 citations

Evaluating a community‐based mental health service focusing on severe mental illness. The Verona experience

2006 • 55 citations

Prolactin level during 5 years of risperidone treatment in patients with psychotic disorders

2007 • 55 citations

Sex, ethnicity, and antipsychotic medication use in patients with psychosis

2003 • 50 citations

Lack of gender differences in neuroleptic response in patients with schizophrenia

1996 • 40 citations

Tardive dyskinesia and antipsychotics: a 5-year longitudinal study of frequency, correlates and course

2005 • 39 citations

Five‐year follow‐up during antipsychotic treatment: efficacy, safety, functional and social outcome

2007 • 37 citations

Symptoms in schizophrenic syndromes in relation to age, sex, duration of illness and number of previous hospitalizations

1994 • 36 citations

Nicotine use and its correlates in patients with psychosis

2007 • 35 citations

The prescription of psychotropic drugs in psychiatric residential facilities: a national survey in Italy

2005 • 34 citations

Weight development in patients treated with risperidone: a 5‐year naturalistic study

2006 • 30 citations

Risperidone Treatment of Outpatients with Schizophrenia: No Evidence of Sex Differences in Treatment Response

2001 • 28 citations

Costs of schizophrenia during 5 years

2007 • 25 citations

Switching Antipsychotics in Inpatient Schizophrenia Care

2004 • 24 citations

Maintenance antipsychotic medication patterns in outpatient schizophrenia patients: a naturalistic cohort study

2005 • 22 citations

How do psychiatrists choose among different antipsychotics?

2005 • 18 citations

Dosage patterns of antipsychotic drugs for the treatment of schizophrenia in Swedish ambulatory clinical practice - a highly individualized therapy

2003 • 17 citations

Neurocognitive and psychopathological correlates of self-monitoring ability in schizophrenia

2004 • 16 citations

Reply to Comments by Drs. Baptista, Kin, and Beaulieu on Novel Antipsychotics and Severe Hyperlipidemia

2002 • 2 citations